Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Electrocardiographic abnormalities in very young Duchenne muscular dystrophy patients precede the onset of cardiac dysfunction.

James J, Kinnett K, Wang Y, Ittenbach RF, Benson DW, Cripe L.

Neuromuscul Disord. 2011 Jul;21(7):462-7. doi: 10.1016/j.nmd.2011.04.005. Epub 2011 May 14.

PMID:
21571532
2.

Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions.

Spurney CF.

Muscle Nerve. 2011 Jul;44(1):8-19. doi: 10.1002/mus.22097. Review.

PMID:
21674516
3.

[From gene to disease; the dystrophin gene involved in Duchenne and Becker muscular dystrophy].

den Dunnen JT, de Visser M, Bakker E.

Ned Tijdschr Geneeskd. 2002 Feb 23;146(8):364-7. Review. Dutch.

PMID:
11887623
4.

Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics.

Fayssoil A, Nardi O, Orlikowski D, Annane D.

Heart Fail Rev. 2010 Jan;15(1):103-7. doi: 10.1007/s10741-009-9156-8. Review.

PMID:
19943106
5.

[Chronologic study of signs of myocardiopathy in progressive muscular dystrophy].

Barona Zamora P, Narbona García J, Alvarez Gómez MJ, Fidalgo Andrés ML, Sáenz de Buruaga J, Villa Elizaga I.

An Esp Pediatr. 1993 Feb;38(2):173-7. Review. Spanish.

PMID:
8439105
6.

New approaches in the therapy of cardiomyopathy in muscular dystrophy.

McNally EM.

Annu Rev Med. 2007;58:75-88. Review.

PMID:
17217326
7.

[Management of myocardial damage in muscular dystrophy].

Tamura T.

Brain Nerve. 2011 Nov;63(11):1217-28. Review. Japanese.

PMID:
22068474
8.

Brain function in Duchenne muscular dystrophy.

Anderson JL, Head SI, Rae C, Morley JW.

Brain. 2002 Jan;125(Pt 1):4-13. Review.

PMID:
11834588
9.

Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach.

Townsend D, Yasuda S, Metzger J.

Expert Rev Cardiovasc Ther. 2007 Jan;5(1):99-109. Review.

PMID:
17187461
10.

[Cardiac involvement in Duchenne muscular dystrophy].

Fayssoil A, Orlikowski D, Nardi O, Annane D.

Presse Med. 2008 Apr;37(4 Pt 2):648-53. Epub 2007 Nov 5. Review. French.

PMID:
17980547
11.

Pathophysiology and therapy of cardiac dysfunction in Duchenne muscular dystrophy.

Judge DP, Kass DA, Thompson WR, Wagner KR.

Am J Cardiovasc Drugs. 2011 Oct 1;11(5):287-94. doi: 10.2165/11594070-000000000-00000. Review.

PMID:
21812510
12.

Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart.

Burelle Y, Khairallah M, Ascah A, Allen BG, Deschepper CF, Petrof BJ, Des Rosiers C.

J Mol Cell Cardiol. 2010 Feb;48(2):310-21. doi: 10.1016/j.yjmcc.2009.09.004. Epub 2009 Sep 18. Review.

13.

Cardiac management in neuromuscular diseases.

Allen HD, Thrush PT, Hoffman TM, Flanigan KM, Mendell JR.

Phys Med Rehabil Clin N Am. 2012 Nov;23(4):855-68. doi: 10.1016/j.pmr.2012.08.001. Review.

PMID:
23137741
14.

A noninvasive means of detecting preclinical cardiomyopathy in Duchenne muscular dystrophy?

Towbin JA.

J Am Coll Cardiol. 2003 Jul 16;42(2):317-8. Review. No abstract available.

15.

Cardiac involvement in Becker muscular dystrophy.

Finsterer J, Stöllberger C.

Can J Cardiol. 2008 Oct;24(10):786-92. Review.

16.

Cardiac involvement in Duchenne and Becker muscular dystrophy.

Mavrogeni S, Markousis-Mavrogenis G, Papavasiliou A, Kolovou G.

World J Cardiol. 2015 Jul 26;7(7):410-4. doi: 10.4330/wjc.v7.i7.410. Review.

17.

Cardiac involvement in dengue infection.

Shivanthan MC, Navinan MR, Constantine GR, Rajapakse S.

J Infect Dev Ctries. 2015 Apr 15;9(4):338-46. doi: 10.3855/jidc.6200. Review.

Supplemental Content

Support Center